Concepedia

Daniel F. Vatner

DF

Statistics

Publications

27

Citations

2.3K

H-Index

21

Active since

1988

Affiliations

Yale University(Current)

Howard Hughes Medical Institute

Veterans Health Administration

Ionis Pharmaceuticals (United States)

VA Connecticut Research and Education Foundation

Daniel F. Vatner is an author at Yale University specializing in life sciences, metabolic regulation, and metabolism.

ORCID

Publications per year

1988–2025

27

Publications

27

Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo

Anila K. Madiraju, Yang Qiu, Rachel J. Perry et al. · Nature Medicine · 2018 · 307 citations · Full text

, , +12

Acetyl‐CoA Carboxylase Inhibition Reverses NAFLD and Hepatic Insulin Resistance but Promotes Hypertriglyceridemia in Rodents

Leigh Goedeke, Jamie Bates, Daniel F. Vatner et al. · Hepatology · 2018 · 251 citations

, , +17

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids

Daniel F. Vatner, Sachin Majumdar, Naoki Kumashiro et al. · Proceedings of the National Academy of Sciences · 2015 · 227 citations · Full text

, , +17

Targeting Pyruvate Carboxylase Reduces Gluconeogenesis and Adiposity and Improves Insulin Resistance

Naoki Kumashiro, Sara A. Beddow, Daniel F. Vatner et al. · Diabetes · 2013 · 161 citations · Full text

, , +17

Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans

Kasper W. ter Horst, Pim W. Gilijamse, Ruth I. Versteeg et al. · Cell Reports · 2017 · 158 citations · Full text

, , +17

1–5 of 27